Know Cancer

forgot password

A Clinical Comparison Trial of White Light Bronchoscopy, Autofluorescence Bronchoscopy and Narrow Band Imaged Bronchoscopy

18 Years
Open (Enrolling)
Lung Cancer

Thank you

Trial Information

A Clinical Comparison Trial of White Light Bronchoscopy, Autofluorescence Bronchoscopy and Narrow Band Imaged Bronchoscopy

Patients with known or suspected malignancies of the lung and with a medical indication for
a bronchoscopy will be invited to participate in the study. All patients must be over 18
years old and must sign informed consent. The endoscopic examination of the bronchial tree
will be performed using a commercially available flexible fluorescence bronchoscope
(11004BI; Karl Storz; Culver City, CA) and the flexible white light video-bronchoscope
(BF-T180; Olympus; Center Valley, PA).

Images obtained will be photographed using both video recordings and parallel images of
white light and imaged bronchoscopy. These digital images will be electronically stored and
evaluated at a later time. Biopsies will be obtained of all suspected abnormalities. These
will be correlated with the images.

Images will be identified as normal, suspect or abnormal based upon each modality
independently, paired with the spectral image and all three combined. The control will be
an area considered normal by all modes of bronchoscopy. Images will be graded at the time
of bronchoscopy. Later, all images will be graded in a blind fashion by two independent
bronchoscopists. Standard statistical analysis using paired Student's t test will be
applied. We anticipate that the combination of one or more imaged bronchoscopy techniques
will increase accuracy by 25%. Power calculation to detect such a difference will require
140 abnormal specimens. If 50% of patients examined have an abnormality, the study
population will need to be around 300 patients.

Histopathology reports will be obtained on all specimens. Abnormal results will be
discussed with the individual patient and appropriate procedures will be performed based
upon best medical practices. These procedures and patient follow-up are beyond the scope of
the study.

Inclusion Criteria:

- Patients with lung abnormalities that have an indication for bronchoscopy

Exclusion Criteria:

- Inability to tolerate bronchoscopy

Type of Study:


Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Degree of correlation between three different bronchoscopic images

Outcome Time Frame:

One day

Safety Issue:


Principal Investigator

Joseph LoCicero, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Maimonides Medical Center


United States: Institutional Review Board

Study ID:




Start Date:

October 2007

Completion Date:

December 2010

Related Keywords:

  • Lung Cancer
  • Bronchoscopy
  • Endoscopy
  • Image Enhancement
  • Autofluorescence
  • Narrow Band Image
  • Lung Neoplasms



Maimonides Medical Center Brooklyn, New York  11219